Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Kynurenines in neurodegenerative disorders: therapeutic consideration.

× No keyword cloud information.

8 in total

Review 1. Novel therapeutics for Alzheimer's disease: an update.

Authors: David J Bonda; Hyun-Pil Lee; Hyoung-gon Lee; Avi L Friedlich; George Perry; Xiongwei Zhu; Mark A Smith
Journal: Curr Opin Drug Discov Devel Date: 2010-03

Review 2. The kynurenine system and immunoregulation.

Authors: Yvette Mándi; László Vécsei
Journal: J Neural Transm (Vienna) Date: 2011-07-09 Impact factor: 3.575

3. A novel kynurenic acid analog (SZR104) inhibits pentylenetetrazole-induced epileptiform seizures. An electrophysiological study : special issue related to kynurenine.

Authors: Ildikó Demeter; Károly Nagy; Levente Gellért; László Vécsei; Ferenc Fülöp; József Toldi
Journal: J Neural Transm (Vienna) Date: 2012-01-10 Impact factor: 3.575

4. Different inhibitory effects of kynurenic acid and a novel kynurenic acid analogue on tumour necrosis factor-α (TNF-α) production by mononuclear cells, HMGB1 production by monocytes and HNP1-3 secretion by neutrophils.

Authors: Zoltán Tiszlavicz; Balázs Németh; Ferenc Fülöp; László Vécsei; Katalin Tápai; Imre Ocsovszky; Yvette Mándi
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2011-02-19 Impact factor: 3.000

5. Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer's disease.

Authors: David J Bonda; Maneesh Mailankot; Jeremy G Stone; Matthew R Garrett; Magdalena Staniszewska; Rudy J Castellani; Sandra L Siedlak; Xiongwei Zhu; Hyoung-gon Lee; George Perry; Ram H Nagaraj; Mark A Smith
Journal: Redox Rep Date: 2010 Impact factor: 4.412

Kynurenines in neurodegenerative disorders: therapeutic consideration.

Review 1. Novel therapeutics for Alzheimer's disease: an update.

Review 2. The kynurenine system and immunoregulation.

3. A novel kynurenic acid analog (SZR104) inhibits pentylenetetrazole-induced epileptiform seizures. An electrophysiological study : special issue related to kynurenine.

4. Different inhibitory effects of kynurenic acid and a novel kynurenic acid analogue on tumour necrosis factor-α (TNF-α) production by mononuclear cells, HMGB1 production by monocytes and HNP1-3 secretion by neutrophils.

5. Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer's disease.

6. The Janus-face kynurenic acid.

Review 7. Neuronal failure in Alzheimer's disease: a view through the oxidative stress looking-glass.

Review 8. Neuroprotection in Parkinson's disease: facts and hopes.